IL17A and inflammatory bowel disease: Our study confirms and extends the notion that circulating T cells co-expressing IL-17A and IFNγ, previously reported both in mouse and human peripheral and mucosal compartments (23), represent a decreased subset of functional T cells appearing as markers several months before IBD relapse episodes.